Shopping Cart
- Remove All
Your shopping cart is currently empty
Low affinity immunoglobulin gamma Fc region receptor II (CD32B) is a single-pass type I membrane protein and contains 2 Ig-like C2-type (immunoglobulin-like) domains. The inhibitory CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target formonoclonal antibody therapy for malignancies.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 μg | $72 | 7-10 days | |
| 10 μg | $116 | 7-10 days | |
| 20 μg | $176 | 7-10 days | |
| 50 μg | $310 | 7-10 days | |
| 100 μg | $532 | 7-10 days | |
| 200 μg | $919 | 7-10 days | |
| 500 μg | $1,900 | 7-10 days | |
| 1 mg | $2,730 | 7-10 days |
| Biological Activity | Loaded Mouse CD32-His on HIS1K Biosensor, can bind Anti-Human HER2 mAb with an affinity constant of 1.14 uM as determined in BLI assay. (Regularly tested) |
| Description | Low affinity immunoglobulin gamma Fc region receptor II (CD32B) is a single-pass type I membrane protein and contains 2 Ig-like C2-type (immunoglobulin-like) domains. The inhibitory CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target formonoclonal antibody therapy for malignancies. |
| Species | Mouse |
| Expression System | HEK293 Cells |
| Tag | C-6xHis |
| Accession Number | P08101 |
| Synonyms | Lymphocyte antigen 17,Ly-17,Low affinity immunoglobulin γ Fc region receptor II,Low affinity immunoglobulin gamma Fc region receptor II,IgG Fc receptor II β,IgG Fc receptor II beta,Fc-γ-RIIB,Fc-γ RII,FcRII,Fcgr2b,Fcgr2,Fc-gamma-RIIB,Fc-gamma RII,Fc γ receptor IIB,Fc gamma receptor IIB,CD32 |
| Amino Acid | Thr30-Pro210 |
| Construction | Thr30-Pro210 |
| Protein Purity | Greater than 95% as determined by reducing SDS-PAGE. (QC verified) |
| Molecular Weight | 33 KDa (reducing condition) |
| Endotoxin | < 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
| Formulation | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. |
| Reconstitution | Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| Stability & Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Shipping | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
| Research Background | Low affinity immunoglobulin gamma Fc region receptor II (CD32B) is a single-pass type I membrane protein and contains 2 Ig-like C2-type (immunoglobulin-like) domains. The inhibitory CD32B is expressed on B cells and myeloid dendritic cells. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation. CD32B may also be a target formonoclonal antibody therapy for malignancies. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.